Baillie Gifford & CO Moderna, Inc. Transaction History

Baillie Gifford & CO

$127 Billion
Q4 2024

A detailed history of Baillie Gifford & CO transactions in Moderna, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 38,889,571 shares of MRNA stock, worth $1.38 Billion. This represents 1.28% of its overall portfolio holdings.

Number of Shares

38,889,571

Previous 42,458,083 8.4%

Holding current value

$1.38 Billion

Previous $2.84 Billion 43.01%

% of portfolio

1.28%

Previous 2.17%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	SELL	$36.85 - $63.93 $131 Million - $228 Million	-3,568,512 Reduced 8.4%	38,889,571 $1.62 Billion
Q3 2024 Nov 05, 2024	SELL	$63.64 - $125.14 $63.1 Million - $124 Million	-990,958 Reduced 2.28%	42,458,083 $2.84 Billion
Q2 2024 Jul 25, 2024	SELL	$101.21 - $166.61 $122 Million - $201 Million	-1,206,776 Reduced 2.7%	43,449,041 $5.16 Billion
Q1 2024 May 01, 2024	SELL	$85.37 - $115.44 $85.3 Million - $115 Million	-998,710 Reduced 2.19%	44,655,817 $4.76 Billion
Q4 2023 Jan 26, 2024	BUY	$69.51 - $104.43 $371,461 - $558,073	5,344 Added 0.01%	45,654,527 $4.54 Billion
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $5.97 Million - $7.84 Million	-61,912 Reduced 0.14%	45,649,183 $4.72 Billion
Q2 2023 Jul 28, 2023	SELL	$118.5 - $160.53 $89.5 Million - $121 Million	-755,076 Reduced 1.63%	45,711,095 $5.55 Billion
Q1 2023 May 03, 2023	BUY	$135.66 - $197.02 $228 Million - $331 Million	1,679,425 Added 3.75%	46,466,171 $7.14 Billion
Q4 2022 Jan 24, 2023	SELL	$118.38 - $210.04 $58.4 Million - $104 Million	-493,277 Reduced 1.09%	44,786,746 $8.04 Billion
Q3 2022 Oct 27, 2022	SELL	$118.07 - $194.18 $33 Million - $54.3 Million	-279,768 Reduced 0.61%	45,280,023 $5.35 Billion
Q2 2022 Aug 08, 2022	SELL	$117.13 - $176.59 $8.13 Million - $12.3 Million	-69,435 Reduced 0.15%	45,559,791 $6.51 Billion
Q1 2022 May 05, 2022	SELL	$126.46 - $235.05 $18.1 Million - $33.6 Million	-142,853 Reduced 0.31%	45,629,226 $7.86 Billion
Q4 2021 Jan 20, 2022	BUY	$225.82 - $368.51 $803 Million - $1.31 Billion	3,554,725 Added 8.42%	45,772,079 $11.6 Billion
Q3 2021 Oct 19, 2021	SELL	$221.9 - $484.47 $813 Million - $1.78 Billion	-3,665,859 Reduced 7.99%	42,217,354 $16.2 Billion
Q2 2021 Aug 02, 2021	BUY	$129.91 - $234.98 $70.9 Million - $128 Million	545,449 Added 1.2%	45,883,213 $10.8 Billion
Q1 2021 May 06, 2021	BUY	$109.18 - $185.98 $2.3 Billion - $3.91 Billion	21,025,493 Added 86.48%	45,337,764 $5.94 Billion
Q4 2020 Feb 10, 2021	BUY	$65.74 - $169.86 $1.12 Billion - $2.9 Billion	17,086,635 Added 236.47%	24,312,271 $2.54 Billion
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $172 Million - $300 Million	3,166,153 Added 77.99%	7,225,636 $511 Million
Q2 2020 Aug 12, 2020	BUY	$29.67 - $80.0 $14.8 Million - $40 Million	499,599 Added 14.03%	4,059,483 $261 Million
Q1 2020 May 08, 2020	BUY	$17.78 - $31.58 $2.56 Million - $4.54 Million	143,771 Added 4.21%	3,559,884 $107 Million
Q4 2019 Feb 10, 2020	BUY	$13.93 - $21.28 $2.8 Million - $4.28 Million	201,316 Added 6.26%	3,416,113 $66.8 Million
Q3 2019 Nov 07, 2019	BUY	$12.26 - $18.07 $88,296 - $130,140	7,202 Added 0.22%	3,214,797 $51.2 Million
Q2 2019 Aug 08, 2019	BUY	$13.7 - $28.34 $8.66 Million - $17.9 Million	632,394 Added 24.56%	3,207,595 $47 Million
Q1 2019 May 01, 2019	BUY	$14.45 - $23.7 $12.3 Million - $20.1 Million	849,357 Added 49.21%	2,575,201 $0
Q4 2018 Feb 14, 2019	BUY	$13.52 - $18.8 $23.3 Million - $32.4 Million	1,725,844 New	1,725,844 $26.4 Million

Others Institutions Holding MRNA

# of Institutions

922

Shares Held

255M

Call Options Held

19M

Put Options Held

24.3M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $13.9B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Account

Baillie Gifford & CO Moderna, Inc. Transaction History